Skip to main content
. 2021 Jul 29;12:547333. doi: 10.3389/fimmu.2021.547333

Figure 1.

Figure 1

The construction of risk score based on significant lncRNAs. Immune-related lncRNAs selected by univariate Cox analysis for TCGA AD patients (A) and TCGA SCC patients (B). KM curve for TCGA AD patients (C), TCGA SCC patients (D), AD patients from validation cohorts (E) and SCC patients from validation cohort (F) in low-risk group and high group based on the risk score.